OI
55
3
PEP
29
2
RCL
85
4
MDT
57
4
AMGN
18
-2
AES
38
3
MHK
48
-5
MMM
63
4
FCX
44
4
DLTR
55
4
XYL
52
5
RRC
69
4
CI
62
-4
HES
43
4
ILMN
44
2
KMI
63
8
RL
76
4
KEY
65
5
SNA
55
12
TRV
45
3
OI
55
3
PEP
29
2
RCL
85
4
MDT
57
4
AMGN
18
-2
AES
38
3
MHK
48
-5
MMM
63
4
FCX
44
4
DLTR
55
4
XYL
52
5
RRC
69
4
CI
62
-4
HES
43
4
ILMN
44
2
KMI
63
8
RL
76
4
KEY
65
5
SNA
55
12
TRV
45
3
Financhill
Back

HCA Healthcare 10K Form

Buy
64

HCA
HCA Healthcare

Last Price:
$348.10
Seasonality Move:
7.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HCA News And Ratings

See the #1 stock for the next 7 days that we like better than HCA

HCA Financial Statistics

Sales & Book Value

Annual Sales: $70.6B
Cash Flow: $660M
Price / Cash Flow: 18.09
Annual Sales: $-14.48
Price / Book: 0

Profitability

EPS (TTM): 22.49000
Net Income (TTM): $5.8B
Gross Margin: $59.8B
Return on Equity: 822.75%
Return on Assets: 9.86%

HCA Healthcare Earnings Forecast

Key HCA Healthcare Financial Ratios

  • The Gross Profit Margin over the past 35 years for HCA is 84.77%.
  • The Selling, General & Administrative Expenses for HCA have been equal to 44.15% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 35.78% of Operating Income.
  • The Net Earning history of HCA is 8.16% of Total Revenues.
  • Per Share Earnings over the last 35 years have been positive in 20 years.

HCA Healthcare Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: HCA
CUSIP: 40412C
Website: hcahealthcare.com

Debt

Debt-to-Equity Ratio: -12.67
Current Ratio: 1.19
Quick Ratio: 0.89

Price-to-Earnings

Trailing P/E Ratio: 15.82
Forward P/E Ratio: 12.43

HCA Technical Analysis vs Fundamental Analysis

Buy
64
HCA Healthcare (HCA) is a Buy

Is HCA Healthcare a Buy or a Sell?

  • HCA Healthcare stock is rated a Buy
    The current HCA Healthcare [HCA] share price is $347.97. The Score for HCA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.